ישראל - עברית - Ministry of Health

j-c health care ltd - etravirine - טבליה - etravirine 100 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti) - containing regimen intelence is not recommended for use in combination with n(t)rtis only.

ישראל - עברית - Ministry of Health

j-c health care ltd - etravirine - טבליה - etravirine 200 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti)- containing regimen intelence is not recommended for use in combination with n(t)rtis only.

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - טבליות מצופות פילם - lenacapavir as sodium 300 mg - lenacapavir

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - תמיסה להזרקה - lenacapavir as sodium 309 mg/ml - lenacapavir

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - ribavirin - קפסולות - ribavirin 200 mg - ribavirin - ribavirin - rebetol is indicated for the treatment of chronic hepatitis c and must only be used as part of a combination regimen with peginterferon alfa-2b (adults) or interferon alfa-2b (adults). rebetol monotherapy must not be used. there is no safety or efficacy information on the use of rebetol with other forms of interferon (i.e., not alfa-2b).previously untreated (na?ve) patients rebetol is indicated in adult patients :• in combination with peginterferon alfa-2b or interferon alfa-2b , for the treatment of adult patients with chronic hepatitis c, not previously treated, without liver decompensation, with elevated alanine aminotransferase (alt), who are positive for serum hcv-rna . additionally, rebetol is indicated , in combination with peginterferon alfa-2b, for the treatment of adult patients with chronic hepatitis c ,not previously treated, without liver decompensation, with elevated alanine aminotransferase (alt), who are positive for serum hcv-rna including patients with clinically stable hiv co-infection. pre

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - טבליות מצופות פילם - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - doravirine - טבליות מצופות פילם - doravirine 100 mg - doravirine

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - doravirine; lamivudine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - doravirine 100 mg; lamivudine 300 mg; tenofovir disoproxil as fumarate 245 mg - lamivudine,tenofovir disoproxil and doravirine

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - efavirenz; emtricitabine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - efavirenz 600 mg; emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - emtricitabine, tenofovir disoproxil and efavirenz

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - ribavirin 200 mg - tablets - ribavirin - copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum hcv-rna, including patients with compensated cirrhosis . the combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable hiv , including patients with compensated cirrhosis . copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.